Masimo (NASDAQ:MASI) Issues Q4 2024 Earnings Guidance

by · The Cerbat Gem

Masimo (NASDAQ:MASI – Get Free Report) updated its fourth quarter 2024 earnings guidance on Tuesday. The company provided EPS guidance of 1.350-1.500 for the period, compared to the consensus EPS estimate of 1.410. The company issued revenue guidance of $581.0 million-$611.0 million, compared to the consensus revenue estimate of $607.4 million. Masimo also updated its FY24 guidance to $3.95-$4.10 EPS.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on MASI. BTIG Research boosted their price objective on Masimo from $166.00 to $170.00 and gave the stock a “buy” rating in a research report on Monday, October 14th. Raymond James upgraded Masimo from a “market perform” rating to an “outperform” rating and set a $170.00 price objective for the company in a research report on Wednesday. Wells Fargo & Company boosted their price objective on Masimo from $160.00 to $171.00 and gave the stock an “overweight” rating in a research report on Wednesday. Piper Sandler boosted their price objective on Masimo from $165.00 to $180.00 and gave the stock an “overweight” rating in a research report on Wednesday. Finally, Needham & Company LLC restated a “hold” rating on shares of Masimo in a research report on Wednesday. Three investment analysts have rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $152.57.

View Our Latest Stock Report on Masimo

Masimo Price Performance

MASI traded up $1.89 during trading on Friday, reaching $163.24. The stock had a trading volume of 98,442 shares, compared to its average volume of 681,002. The firm has a market capitalization of $8.68 billion, a price-to-earnings ratio of 112.44 and a beta of 0.97. Masimo has a 1-year low of $81.82 and a 1-year high of $173.90. The stock has a 50 day moving average of $132.63 and a two-hundred day moving average of $125.88. The company has a quick ratio of 1.15, a current ratio of 2.09 and a debt-to-equity ratio of 0.55.

Masimo (NASDAQ:MASI – Get Free Report) last posted its quarterly earnings results on Tuesday, November 5th. The medical equipment provider reported $0.98 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.84 by $0.14. The company had revenue of $504.60 million for the quarter, compared to analysts’ expectations of $502.87 million. Masimo had a return on equity of 14.07% and a net margin of 3.94%. The firm’s revenue was up 5.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.63 earnings per share. As a group, equities analysts anticipate that Masimo will post 3.88 EPS for the current fiscal year.

Masimo Company Profile

(Get Free Report)

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.

See Also